carnosine has been researched along with Degenerative Diseases, Central Nervous System in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chmielewska, K; Dzierzbicka, K; Inkielewicz-Stępniak, I; Przybyłowska, M | 1 |
| Kato-Negishi, M; Kawahara, M; Tanaka, KI | 1 |
| Artioli, GG; Jones, RL; Sale, C | 1 |
| Abaimov, DA; Berezhnoy, DS; Devyatov, AA; Fedorova, TN; Kulikova, OI; Lopachev, AV; Lopacheva, OM; Stvolinsky, SL | 1 |
| Caraci, F; Caruso, G; Jolivet, RB | 1 |
| Barone, E; Bates, T; Calabrese, V; Calafato, S; Cornelius, C; Kostova, AT; Mancuso, C; Rizzarelli, E | 1 |
| Boldyrev, AA | 1 |
| Abe, H; Boldyrev, AA; Bulygina, ER; Fedorova, TN; Meguro, K; Sato, T; Stvolinsky, SL; Tyulina, OV | 1 |
| Bellia, F; Calabrese, V; Cuzzocrea, S; Rizzarelli, E; Vecchio, G | 1 |
| Choi, SY; Hoon Kang, J; Jeong, MS; Kim, NH | 1 |
| Hipkiss, AR | 1 |
8 review(s) available for carnosine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human Diseases.
Topics: Carnosine; Diabetes Mellitus; Humans; Molecular Conformation; Neoplasms; Neurodegenerative Diseases; Schizophrenia | 2020 |
Zinc, Carnosine, and Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyloidogenic Proteins; Animals; Antioxidants; Brain; Carnosine; Chelating Agents; Dementia, Vascular; Dietary Supplements; Disease Models, Animal; Homeostasis; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Prion Diseases; Zinc | 2018 |
Carnosine in health and disease.
Topics: Acute Kidney Injury; Aging; Brain; Carnosine; Cognition; Diabetes Mellitus, Type 2; Heart; Humans; Kidney; Muscle, Skeletal; Neoplasms; Neurodegenerative Diseases; Pancreas; Performance-Enhancing Substances | 2019 |
Carnosine as an effective neuroprotector in brain pathology and potential neuromodulator in normal conditions.
Topics: Animals; Brain Ischemia; Carnosine; Homeostasis; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Neurotransmitter Agents | 2019 |
Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Diseases, Metabolic, Inborn; Carnosine; Dipeptidases; Humans; Neurodegenerative Diseases | 2019 |
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases.
Topics: Antioxidants; Carnitine; Carnosine; Curcumin; Dietary Supplements; Heme Oxygenase (Decyclizing); HSP70 Heat-Shock Proteins; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Thioredoxin-Disulfide Reductase | 2009 |
Molecular mechanisms of homocysteine toxicity.
Topics: Animals; Apoptosis; Blood Cells; Cardiovascular Diseases; Carnosine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Neurodegenerative Diseases; Neurons; Pregnancy; Receptors, N-Methyl-D-Aspartate; Risk Factors | 2009 |
Neuroprotective features of carnosine in oxidative driven diseases.
Topics: Animals; Brain; Carnosine; Dipeptidases; Humans; Neurodegenerative Diseases; Oxidative Stress | 2011 |
3 other study(ies) available for carnosine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Biological activity of novel synthetic derivatives of carnosine.
Topics: Animals; Antioxidants; Biphenyl Compounds; Brain; Carnosine; Cells, Cultured; Cerebellar Cortex; Chromans; Dipeptidases; Erythrocytes; Hemolysis; Humans; Hydrogen Peroxide; Iron; Lipid Peroxidation; Molecular Structure; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Oxidants; Oxidative Stress; Picrates; Rats; Reactive Oxygen Species | 2010 |
Oxidative modification of neurofilament-L by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Topics: Animals; Anserine; Carnosine; Copper; Hydrogen Peroxide; Mice; Neurodegenerative Diseases; Neurofilament Proteins; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Zinc | 2004 |
Could carnosine suppress zinc-mediated proteasome inhibition and neurodegeneration? Therapeutic potential of a non-toxic but non-patentable dipeptide.
Topics: Animals; Carnosine; Dipeptides; Humans; Models, Neurological; Neurodegenerative Diseases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Zinc | 2005 |